(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

U

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

U

ST13

US500000097372711

Class

5, 40, 42, 44

Filing

97372711

Registration

7580622

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

11/26/2024

Trademark type

Combined

Nice classes

5, 40, 42, 44

Filing date

04/20/2022

Registration date

11/26/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/26/2024

Last transaction

11/26/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2024-05-00

First use in commerce

2024-05-00

Drawing code

5

Owner type

03

Owner location

Seattle, WA

Examiner

RINGLE, JAMES W

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a stylized "U".

Holders and representatives

Holders

Umoja Biopharma, Inc.

Representatives

Mark A. Jansen Fenwick & West LLP

Technical classification

Nice Classes

Class 5Class 40Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for the treatment of cancer

Class 40

Manufacturing services for others in the field of pharmaceutical preparations

Class 42

Medical research and scientific research in the fields of immunotherapy and oncology; Medical research consulting and scientific research consulting services in the fields of immunotherapy and oncology

Class 44

Medical consulting services in the fields of immunotherapy and oncology

Publications

History of USPTO decisions and trademark events.

32 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/26/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/26/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/07/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/07/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/06/2024

IUAF

USE AMENDMENT FILED

10/28/2024

EISU

TEAS STATEMENT OF USE RECEIVED

10/28/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/08/2024

EX2G

SOU EXTENSION 2 GRANTED

05/07/2024

EXT2

SOU EXTENSION 2 FILED

05/07/2024

EEXT

SOU TEAS EXTENSION RECEIVED

05/07/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/16/2023

EX1G

SOU EXTENSION 1 GRANTED

11/15/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/15/2023

EXT1

SOU EXTENSION 1 FILED

11/08/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/08/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/16/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/08/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/08/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/08/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/08/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/08/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/21/2023

PUBO

PUBLISHED FOR OPPOSITION

03/21/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/01/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/13/2023

DOCK

ASSIGNED TO EXAMINER

02/07/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/24/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/24/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/24/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/26/2022

NWAP

NEW APPLICATION ENTERED

04/23/2022

Continuous trademark protection

Get notified about every new filing that threatens U or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.